In 2016, AASLD launched the Innovation Fund to identify and support new ideas for enhancing the society’s mission. Awards of $10,000 to $60,000 are available for one- to two-year innovative projects.
Nine projects have been funded so far.
Cycle 1 Recipients
- NAFLD Simulator: An Online Tool for Predicting Long-Term Patient Outcomes
Project lead: Jag Chhatwal, PhD / Nonalcoholic Fatty Liver Disease SIG
Description: This project will develop an online, open-access tool, NAFLD Simulator, that will simulate the life course of patients with NAFLD and provide information on the long-term risks. The creators envision that NAFLD Simulator will serve as an educational tool in the clinical setting and aid in shared patient/physician decision-making.
- Building a novel medication adherence mHealth application for adolescents and young adult liver transplant patients
Project lead: Pooja Mehta, MD, MSCI / Pediatric Liver SIG
Description: The goal of this project is to develop a mHealth app to improve medication adherence among adolescent and young adult liver transplant recipients.
Cycle 2 Recipients
- LiveRight: Improving Immunosuppressant Adherence and Liver Transplant Outcomes Using Patient-Centered Smartphone Technology
Project lead: Sarah R. Lieber, MD / Liver Transplantation and Surgery SIG
Description: This project seeks to develop “LiveRight”— a unique app designed specifically for liver transplant recipients and their caregivers featuring liver transplant education, a personalized patient portal, medication reminders, and virtual support/chat rooms among other features aimed to influence behavior change.
Cycle 1 Recipients
- Social Media Essentials
Project lead: Communications and Technology Committee
Description: AASLD's Social Media Essentials provides the tools you need to join, engage and thrive in a social health care environment.
- Development of an Electronic Causality Assessment Tool for Diagnosis of Drug-Induced Liver Injury
Project lead: Paul Hayashi, MD, MPH / Hepatotoxicity SIG
Description: This project aims to revise the Roussel Uclaf Causality Assessment Method (RUCAM) for diagnosing drug-induced liver injury (DILI) into a user-friendly and accurate diagnostic and make the revised RUCAM widely available through a computerized application.
Cycle 2 Recipients
- Development of an App to Predict ACLF and Mortality in Cirrhotic Inpatients
Project lead: Jasmohan S. Bajaj, MD, FAASLD / Acute on Chronic Liver Failure SIG
Description: This project will develop an interactive App and website that can be used at the bedside for the prediction of outcomes in patients with ACLF, with calculators for the development of organ failure, ACLF, risk factors associated with hospital readmissions and 30- and 90-day mortality based on models created from the newly completed NACSELD registry of >3000 cirrhotic inpatients.
- EL-Fit: The Physical Fitness App for End-Stage Liver Disease
Project lead: Andres Duarte-Rojo, MD, DSc / Clinical Practice SIG
Description: This project aims to develop a smartphone app called EL-Fit (End-stage Liver disease Fitness) which will allow patients with cirrhosis and ESLD to undergo home-based physical training.
- Hepatology Curriculum for Medical Students
Project lead: Steven K. Herrine, MD, FAASLD / Membership and Mentorship Committee
Description: The Hepatology Curriculum for Medical Students (HCMS) will be a modular, highly-dynamic online platform on which standardized and cutting-edge hepatology content will be accessible to students across the United States through the AASLD LiverLearning® site to supplement comprehensive exposure for those who lack access to the field of hepatology. HCMS will allow medical students to access materials, research and professional mentors through their devices -- smartphones, tablets and computers -- as teaching is quickly expanding beyond the walls of the classroom.
- Effect of Smartphone Remote Monitoring in Predicting Outcomes in Patients with Cirrhosis
Project lead: Nikroo Hashemi, MD, MPH / Public Health/Health Care Delivery SIG
Description: This project's aim is to evaluate the effectiveness of Remote Patient Monitoring (RPM) in cirrhotics in detecting early warning signs before acute decompensation requiring hospitalization occurs.
Any AASLD member may apply, but applications must be submitted through a SIG or committee. Interested applicants should submit a Letter of Inquiry to determine Committee/SIG interest in sponsoring their application. Letters should be addressed to the appropriate Committee Chair or SIG Chair and emailed to Julia Merrill at firstname.lastname@example.org.
For more information about the Innovation Fund and the application process, visit aasld.org/innovationfund.